Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie Lacroix

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Plos One|December 16, 2014
Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell lineSteven Bhutra, Divya Lenkala, Bonnie LaCroix, et al.
Plos One|April 5, 2014
Integrative "omic" analysis for tamoxifen sensitivity through cell based modelsLiming Weng, Dana Ziliak, Bonnie Lacroix, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 1, 2015
MicroRNA biogenesis and cellular proliferationDivya Lenkala, Eric R Gamazon, Bonnie LaCroix, et al.
Molecular Cancer Therapeutics|July 4, 2012
Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibilityDana Ziliak, Eric R Gamazon, Bonnie Lacroix, et al.
Human Genetics|March 11, 2014
The impact of microRNA expression on cellular proliferationDivya Lenkala, Bonnie LaCroix, Eric R Gamazon, et al.
American Journal of Human Genetics|June 5, 2012
Genetic architecture of microRNA expression: implications for the transcriptome and complex traitsEric R Gamazon, Dana Ziliak, Hae Kyung Im, et al.
BMC Genomics|April 18, 2014
Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivityBonnie LaCroix, Eric R Gamazon, Divya Lenkala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2019
Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer DisparitiesTimothy J Robinson, Jennifer A Freedman, Muthana Al Abo, et al.
Journal of the National Cancer Institute|August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput GenomicsPaul Geeleher, Andrey Loboda, Divya Lenkala, et al.
Oncotarget|May 26, 2016
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patientsGladys Morrison, Divya Lenkala, Bonnie LaCroix, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Plos One|December 16, 2014
Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell lineSteven Bhutra, Divya Lenkala, Bonnie LaCroix, et al.
Plos One|April 5, 2014
Integrative "omic" analysis for tamoxifen sensitivity through cell based modelsLiming Weng, Dana Ziliak, Bonnie Lacroix, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 1, 2015
MicroRNA biogenesis and cellular proliferationDivya Lenkala, Eric R Gamazon, Bonnie LaCroix, et al.
Molecular Cancer Therapeutics|July 4, 2012
Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibilityDana Ziliak, Eric R Gamazon, Bonnie Lacroix, et al.
Human Genetics|March 11, 2014
The impact of microRNA expression on cellular proliferationDivya Lenkala, Bonnie LaCroix, Eric R Gamazon, et al.
American Journal of Human Genetics|June 5, 2012
Genetic architecture of microRNA expression: implications for the transcriptome and complex traitsEric R Gamazon, Dana Ziliak, Hae Kyung Im, et al.
BMC Genomics|April 18, 2014
Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivityBonnie LaCroix, Eric R Gamazon, Divya Lenkala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2019
Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer DisparitiesTimothy J Robinson, Jennifer A Freedman, Muthana Al Abo, et al.
Journal of the National Cancer Institute|August 23, 2015
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput GenomicsPaul Geeleher, Andrey Loboda, Divya Lenkala, et al.
Oncotarget|May 26, 2016
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patientsGladys Morrison, Divya Lenkala, Bonnie LaCroix, et al.
Pageof 2